Journal article · 2026
Cardiovascular risk associated with first-line Janus kinase inhibitors versus TNF inhibitors in patients with RA: a nationwide cohort study
Rheumatology, 65(10) · Published 1 October 2026 · DOI 10.1093/rheumatology/keag582
In brief
“Cardiovascular risk associated with first-line Janus kinase inhibitors versus TNF inhibitors in patients with RA: a nationwide cohort study” is a 2026 journal article by Oh Chan Kwon and 3 co-authors, published in Rheumatology. OpenAlex counts 0 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- References
- 31
- Authors
- 4
Abstract
OBJECTIVE: To compare the risk of major adverse cardiovascular events (MACEs) between TNF inhibitors (TNFi) and Janus kinase inhibitors (JAKi) when initiated as first-line advanced therapy in patients with RA. METHODS: Using the Korean nationwide claims database, we identified patients newly diagnosed with RA between 2010 and 2015. Patients who initiated TNFi or JAKi as… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Kwon, O. C., Lee, H. S., Jeon, S. Y., & Park, M.-C. (2026). Cardiovascular risk associated with first-line Janus kinase inhibitors versus TNF inhibitors in patients with RA: a nationwide cohort study. Rheumatology, 65(10). https://doi.org/10.1093/rheumatology/keag582
MLA 9
Kwon, Oh Chan, et al. “Cardiovascular risk associated with first-line Janus kinase inhibitors versus TNF inhibitors in patients with RA: a nationwide cohort study.” Rheumatology, vol. 65, no. 10, 2026. https://doi.org/10.1093/rheumatology/keag582.
Chicago
Kwon, Oh Chan, Hye Sun Lee, So Young Jeon, and Min-Chan Park. 2026. “Cardiovascular risk associated with first-line Janus kinase inhibitors versus TNF inhibitors in patients with RA: a nationwide cohort study.” Rheumatology 65 (10). https://doi.org/10.1093/rheumatology/keag582.
Harvard
Kwon, O. C. et al. (2026) ‘Cardiovascular risk associated with first-line Janus kinase inhibitors versus TNF inhibitors in patients with RA: a nationwide cohort study’, Rheumatology, 65(10). doi:10.1093/rheumatology/keag582.
IEEE
O. C. Kwon, H. S. Lee, S. Y. Jeon, and M.-C. Park, “Cardiovascular risk associated with first-line Janus kinase inhibitors versus TNF inhibitors in patients with RA: a nationwide cohort study,” Rheumatology, vol. 65, no. 10, 2026, doi: 10.1093/rheumatology/keag582.
BibTeX
@article{kwon2026cardiovascular,
title = {{Cardiovascular risk associated with first-line Janus kinase inhibitors versus TNF inhibitors in patients with RA: a nationwide cohort study}},
author = {Kwon, Oh Chan and Lee, Hye Sun and Jeon, So Young and Park, Min-Chan},
journal = {Rheumatology},
year = {2026},
volume = {65},
number = {10},
doi = {10.1093/rheumatology/keag582},
url = {https://doi.org/10.1093/rheumatology/keag582}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- rheumatoid arthritis
- JAK inhibitors
- TNF-alpha inhibitors
- major adverse cardiovascular events
- cardiovascular safety
- myocardial infarction
- ischemic stroke
- coronary revascularization
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Kwon, O. C., Lee, H. S., Jeon, S. Y., & Park, M.-C. (2026). Cardiovascular risk associated with first-line Janus kinase inhibitors versus TNF inhibitors in patients with RA: a nationwide cohort study. Rheumatology, 65(10). https://doi.org/10.1093/rheumatology/keag582
How many times has this paper been cited?
0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Oh Chan Kwon, Hye Sun Lee, So Young Jeon, Min-Chan Park.
What is the DOI of this paper?
10.1093/rheumatology/keag582, permanently at https://doi.org/10.1093/rheumatology/keag582. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.